Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8

Core Insights - Prenetics Global Limited has strategically realigned its focus exclusively on its consumer health brand IM8, ceasing all Bitcoin acquisition activities to capitalize on IM8's growth potential [1][4][5] - IM8 has achieved remarkable success, becoming the fastest-growing supplement brand in history, with over $100 million in annualized recurring revenue (ARR) within just 11 months of its launch [2][6] - The company maintains a strong financial position with over $70 million in cash, 510 BTC as a treasury reserve, and no debt, providing a solid foundation for the expansion of IM8 [3][4] Company Strategy - The decision to focus solely on IM8 is aimed at maximizing long-term shareholder value and reflects the company's commitment to disciplined governance and strategic clarity [5][3] - Capital allocation will be directed exclusively towards the growth and operations of IM8, including product innovation, brand building, talent acquisition, working capital, and international expansion [4][5] Product Overview - IM8 is positioned as a premium core nutrition brand, co-founded by David Beckham, and combines advanced science with natural ingredients to promote health and longevity [6][7] - The flagship product, Daily Ultimate Essentials, is designed to replace 16 different supplements in a single drink and is certified for sport, non-GMO, vegan, and free from common allergens [7]